Moreover, a mathematical modeling approach has also been used to describe the key AD clinical biomarkers including pathologic hallmark biomarkers (beta-amyloid and tau), neuronal loss biomarkers, and cognitive impairment10. Here, MAPT is linked to Alzheimer disease.